Infertility: Clinical Trials

215 trials for Infertility, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

110 completed, 49 unknown, 16 recruiting, 16 terminated. 215 Phase 2, 57 Phase 3, 37 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 2215Completed 110, Unknown 49, Recruiting 16, Terminated 16, Not yet recruiting 8, Withdrawn 8, Active not recruiting 4, Suspended 3, Enrolling by invitation 1
Phase 357Completed 30, Unknown 9, Recruiting 8, Terminated 5, Withdrawn 4, Suspended 1
Phase 137Completed 16, Unknown 12, Recruiting 4, Active not recruiting 2, Not yet recruiting 1, Terminated 1, Withdrawn 1

Follow Infertility: new trials by email Literature Review of Infertility trials Research Report on Infertility

Trials (filtered) newest first · largest first

All 215 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PRECISION-E2: Teverelix in Women With Endometriosis - Pharmacodynamics, Safety and Precision Medicine Correlates
Teverelix DP, Teverelix DP Placebo - Endometriosis Pelvic, Endometriosis Ovaries
Phase 2Not yet recruitingAntev Ltd.842027-02-012026-11-03
Opt-IVF for Personalized Medicine for Normal Responders
Opt-IVF, control - Ivf
Phase 1 / Phase 2Active not recruitingUrmila DIwekar1002026-10-152026-11-03
Uterine Transplant in Absolute Uterine Infertility (AUIF)
Uterine Transplant - Female Infertility
Phase 2 / Phase 3WithdrawnBrigham and Women's Hospital2026-09-012026-10-15
Drospirenone-Primed Ovarian Stimulation Versus GnRH Antagonist Protocol in Poor Ovarian Responders Undergoing Freeze-All IVF/ICSI
Drospirenone drug, Cetrorelix 0.25 mg - Poor Ovarian Reserve, Infertility (IVF Patients)
Phase 1 / Phase 2Not yet recruitingAhmed Saad1002026-08-012026-07-30
Triggering Ovulation in Normo-responders Using a Modified Dual Trigger Protocol or HCG Trigger
Modified dual trigger, HCG - Infertility (IVF Patients)
Phase 2Not yet recruitingBedaya Hospital1962026-06-012026-05-06
Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger
Double trigger, HCG trigger - Infertility
Phase 2Not yet recruitingBedaya Hospital1642026-06-012026-05-06
Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-responders
Successive doses GnRH agonist, Single dose GnRH agonist - Infertility
Phase 2Not yet recruitingBedaya Hospital1902026-06-012026-05-11
Can Fat-Burning Shots Boost Fertility? Comparing Weight-Loss Injections vs. Healthy Habits for Obese Men With Low Sperm Health
Semaglutide (Rybelsus®), Tirzepatide, Standardized Lifestyle Intervention - Obesity-related Male Infertility
Phase 2Not yet recruitingFirst Affiliated Hospital of Wenzhou Medical University1802026-05-012025-09-17
A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoospermia
Leflutrozole, Dose 2 - Infertility Due to Azoospermia, Infertility, Male
Phase 1 / Phase 2Active not recruitingMartin Blomberg Jensen152026-04-212026-10-21
Isotretinoin vs hCG for Male Infertility Due to Low or Absent Sperm
isotretinoin, Human chorionic gonadotrophin (hCG) - Oligospermia, Azoospermia, Nonobstructive
Phase 2Enrolling by invitationUniversity of Nebraska1002026-04-132026-04-20
A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
Mibavademab, Placebo - Functional Hypothalamic Amenorrhea, FHA
Phase 2RecruitingRegeneron Pharmaceuticals342026-03-112026-11-04
Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauterine Successful Experience (RISE)
REKOVELLE (Follitropin Delta) - Infertility, Insemination
Phase 2RecruitingCentre Hospitalier Intercommunal Creteil802025-12-172026-04-08
PKB171 Against Placebo in Couples With Mild Male Factor Infertility
Intravaginal gel, Vaginal Gel with Applicator - Infertility Due to Azoospermia
Phase 2 / Phase 3RecruitingProkrea BCN, S.L.7322025-10-282026-06-25
Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization
Somatropin (4IU for 1 month) plus, folic acid 400 mcg per day., DHEA plus folic acid 400mcg per day, control group - Infertility, Infertility (IVF Patients)
Phase 2 / Phase 3RecruitingBeni-Suef University1652025-10-102026-01-07
An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera
Opt-IVF, Control - Infertility (IVF Patients)
Phase 1 / Phase 2RecruitingUrmila DIwekar2002025-09-232025-09-29
NT-NOA - Novel Treatment of Some Men With Non-Obstructive Azoospermia
Denosumab (Prolia), Letrozole (Aromatase Inhibitors) - Infertility, Male
Phase 1 / Phase 2CompletedMartin Blomberg Jensen162025-03-012026-10-21
Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
Estradiol Patches - Infertility, Female, Obesity
Phase 2RecruitingUniversity of Colorado, Denver202025-02-252026-07-21
Evaluating Mechanically Engineered Stem Cell Exosomes for Treating Endometrial Injury: A Clinical Study
Mechanically Engineered Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes, Umbilical cord mesenchymal stem cell-derived exosomes, platelet-rich plasma - Thin Endometrial Lining, Female Infertility
Phase 1 / Phase 2RecruitingTang-Du Hospital902025-02-212025-03-26
Supplementation for Male Subfertility
Active multi-ingredient supplement (Fertility Enhancer, FE), Inactive placebo (Placebo; PLA) - Male Infertility
Phase 2Not yet recruitingHamilton Health Sciences Corporation642025-01-012024-10-10
Study of Tolerability, Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Medicinal Product MediReg®
Medicinal product MediReg® (Human Mesenchymal Stromal Cell Secretome), lyophilizate for preparation of solution for injection in patients with severe spermatogenesis disorders, Clostilbegit (clomiphene) 50 mg 1 tablet x 1 p a day - 3 months, Triovit - 1 tablet x 1 p a day - 3 months, Folic acid - 1 tablet x 1 p a day - 3 months. - Azoospermia, Nonobstructive, Teratospermia
Phase 1 / Phase 2RecruitingLomonosov Moscow State University Medical Research and Educational Center802024-11-262025-03-11

Showing 20 of 215. Sign in to see all of them.

Narrower conditions

Infertility, Female (37)  ·  Infertility, Male (31)  ·  Endometriosis (12)  ·  Obesity (8)  ·  Oligospermia (8)  ·  Polycystic Ovary Syndrome (8)  ·  Asthenozoospermia (6)  ·  Azoospermia (6)  ·  Hypogonadism (5)  ·  Dysmenorrhea (4)  ·  Dyspareunia (4)  ·  Endometrial Hyperplasia (4)  ·  Gynatresia (4)  ·  Pelvic Pain (4)

Broader conditions

Genital Diseases (215)  ·  Urogenital Diseases (215)  ·  Female Urogenital Diseases and Pregnancy Complications (66)  ·  Female Urogenital Diseases (63)  ·  Genital Diseases, Female (60)  ·  Male Urogenital Diseases (47)  ·  Genital Diseases, Male (45)  ·  Pathological Conditions, Signs and Symptoms (20)  ·  Endocrine System Diseases (16)  ·  Signs and Symptoms (16)  ·  Gonadal Disorders (15)  ·  Neoplasms (12)  ·  Nutritional and Metabolic Diseases (10)  ·  Pathologic Processes (10)

Interventions

Clomiphene (14)  ·  Chorionic Gonadotropin (10)  ·  Sodium Chloride (9)  ·  Gonadotropin-Releasing Hormone (8)  ·  follitropin alfa (8)  ·  Cabergoline (7)  ·  Letrozole (7)  ·  Triptorelin Pamoate (6)  ·  follicle stimulating hormone, human, with HCG C-terminal peptide (6)  ·  Denosumab (5)  ·  Folic Acid (5)  ·  Glycoprotein Hormones, alpha Subunit (5)  ·  Luteinizing Hormone, beta Subunit (5)  ·  Metformin (5)  ·  cetrorelix (5)

Sponsors

Benha University (8)  ·  Ferring Pharmaceuticals (7)  ·  Cairo University (6)  ·  Martin Blomberg Jensen (6)  ·  Merck KGaA, Darmstadt, Germany (6)  ·  Royan Institute (6)  ·  Bedaya Hospital (5)  ·  Genesis Athens Clinic (5)  ·  National and Kapodistrian University of Athens (5)  ·  Ain Shams University (4)  ·  Aljazeera Hospital (4)  ·  Assiut University (4)  ·  Riyadh Fertility and Reproductive Health center (4)  ·  Abbott (3)  ·  Al-Azhar University (3)

Countries

Egypt (46)  ·  United States (37)  ·  Spain (14)  ·  Denmark (13)  ·  China (11)  ·  Greece (11)  ·  Canada (10)  ·  Iran (9)  ·  Belgium (6)  ·  Czechia (5)  ·  United Kingdom (5)  ·  Italy (4)  ·  Poland (4)  ·  Russia (4)  ·  Iraq (3)

Top investigators

Usama M Fouda, Prof. (4)  ·  Santiago Munne, PhD (3)  ·  Usama M Fouda, M.D, PhD (3)  ·  Agni Pantou, MD (2)  ·  Ahmed M Sayed, M.D, PhD (2)  ·  David H Barad, MD, MS (2)  ·  Dina M Dakhly, MD (2)  ·  Hamid Gourabi, PhD (2)  ·  Nanette Santoro, MD (2)

Results publications

PMID 33851429, PMID 34792133, PMID 37699851, PMID 10548619, PMID 11228933, PMID 12516764, PMID 14561807, PMID 15126522, PMID 15579793, PMID 17197592, PMID 18281242, PMID 18343810, PMID 18675974, PMID 18678368, PMID 18783876, PMID 19381855, PMID 19729414, PMID 19910321, PMID 20031032, PMID 20149360, PMID 20672903, PMID 21575849, PMID 21693030, PMID 21703683, PMID 21714697, PMID 21806579, PMID 21853931, PMID 22081410, PMID 22197127, PMID 22459631, PMID 22464760, PMID 22740496, PMID 22748101, PMID 22877941, PMID 22895856, PMID 23106834, PMID 23292545, PMID 23341491, PMID 23357459, PMID 23431372, PMID 23518033, PMID 23757979, PMID 23900207, PMID 24097378, PMID 24424357, PMID 24695882, PMID 24812310, PMID 25036713, PMID 25256937, PMID 25274200

NIH funding

2015 (2), 2016 (2), 2023 (2), 2008 (1), 2018 (1), 2025 (1), K24HD082231 (1), P30CA016672 (1), P50CA090270 (1), U10CA031946 (1), U54HD028138 (1)